Mirum Pharmaceuticals Inc (MIRM) USD0.0001
1.96%- This stock can be held in a
Stocks and Shares ISASell:$39.66
Buy:$49.84
Change:
$0.45
(1.00%)
$0.45
(1.00%)Market closed | Prices delayed by at least 15 minutes
Sell:$39.66
Buy:$49.84
Change:$0.45
(1.00%)
$0.45
(1.00%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 11 March 2025 | FRAZIER LIFE SCIENCES IX L PVenture Capital | Buy Regular purchase transaction | 963 | $43.77 | $42,155.13 | 168,123 |
| 10 March 2025 | FRAZIER LIFE SCIENCES IX L PVenture Capital | Buy Regular purchase transaction | 577 | $43.37 | $25,023.34 | 167,160 |
| 10 March 2025 | FRAZIER LIFE SCIENCES IX L PVenture Capital | Buy Regular purchase transaction | 758 | $42.66 | $32,339.46 | 166,583 |
| 7 March 2025 | FRAZIER LIFE SCIENCES IX L PVenture Capital | Buy Regular purchase transaction | 580 | $43.21 | $25,064.41 | 165,825 |
| 6 March 2025 | FRAZIER LIFE SCIENCES IX L PVenture Capital | Buy Regular purchase transaction | 1,335 | $43.89 | $58,596.89 | 165,245 |
| 5 March 2025 | FRAZIER LIFE SCIENCES IX L PVenture Capital | Buy Regular purchase transaction | 267 | $44.55 | $11,893.52 | 163,910 |
| 4 March 2025 | FRAZIER LIFE SCIENCES IX L PVenture Capital | Buy Regular purchase transaction | 56 | $45.96 | $2,573.74 | 163,643 |
| 4 March 2025 | FRAZIER LIFE SCIENCES IX L PVenture Capital | Buy Regular purchase transaction | 1,279 | $45.55 | $58,256.66 | 163,587 |
| 4 March 2025 | Peter RadovichPresident/COO | Sell Regular sell transaction (market) | 13,681 | $45.57 | $623,458.22 | 13,280 |
| 4 March 2025 | Peter RadovichPresident/COO | Sell Regular sell transaction (market) | 1,169 | $45.74 | $53,470.06 | 12,111 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 24 June 2024 | Pamela VigChief Level Officer | Sell Option/Award related | 30,559 | $34.00 | $1,039,006.00 | 27,406 |
| 3 March 2025 | Christopher PeetzCEO | Sell Option/Award related | 20,608 | $47.19 | $972,491.52 | 115,920 |
| 3 March 2025 | Christopher PeetzCEO | Sell Option/Award related | 19,392 | $46.61 | $903,861.12 | 136,528 |
| 4 March 2025 | Peter RadovichPresident/COO | Sell Regular sell transaction (market) | 13,681 | $45.57 | $623,458.22 | 13,280 |
| 3 February 2025 | Christopher PeetzCEO | Sell Tax related | 9,102 | $48.22 | $438,921.20 | 115,920 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.